Annual EBITDA
-$94.46 M
+$12.74 M+11.89%
December 1, 2023
Summary
- As of February 22, 2025, MAZE annual EBITDA is -$94.46 million, with the most recent change of +$12.74 million (+11.89%) on December 1, 2023.
- During the last 3 years, MAZE annual EBITDA has risen by +$12.74 million (+11.89%).
Performance
MAZE EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBITDA
-$23.44 M
NaN%
September 1, 2024
Summary
- As of February 22, 2025, MAZE quarterly EBITDA is -$23.44 million
Performance
MAZE Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBITDA
-$45.52 M
NaN%
September 1, 2024
Summary
- As of February 22, 2025, MAZE TTM EBITDA is -$45.52 million
Performance
MAZE TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
MAZE EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +11.9% | - | - |
| 3 y3 years | +11.9% | - | - |
| 5 y5 years | +11.9% | - | - |
MAZE EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +13.5% | +6.2% | +3.3% | +87.9% | +1.7% |
| 5 y | 5-year | at high | +13.5% | +6.2% | +3.3% | +87.9% | +1.7% |
| alltime | all time | at high | +13.5% | +6.2% | +3.3% | +87.9% | +1.7% |
Maze Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$23.44 M(+6.2%) | -$45.52 M(-1.7%) |
| Dec 2023 | -$94.46 M | -$22.07 M(-8.9%) | -$46.30 M(+91.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$24.22 M | -$24.22 M |
| Dec 2022 | -$107.21 M | - | - |
FAQ
- What is Maze Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Maze Therapeutics?
- What is Maze Therapeutics annual EBITDA year-on-year change?
- What is Maze Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Maze Therapeutics?
- What is Maze Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Maze Therapeutics?
What is Maze Therapeutics annual EBITDA?
The current annual EBITDA of MAZE is -$94.46 M
What is the all time high annual EBITDA for Maze Therapeutics?
Maze Therapeutics all-time high annual EBITDA is -$94.46 M
What is Maze Therapeutics annual EBITDA year-on-year change?
Over the past year, MAZE annual EBITDA has changed by +$12.74 M (+11.89%)
What is Maze Therapeutics quarterly EBITDA?
The current quarterly EBITDA of MAZE is -$23.44 M
What is the all time high quarterly EBITDA for Maze Therapeutics?
Maze Therapeutics all-time high quarterly EBITDA is -$22.07 M
What is Maze Therapeutics TTM EBITDA?
The current TTM EBITDA of MAZE is -$45.52 M
What is the all time high TTM EBITDA for Maze Therapeutics?
Maze Therapeutics all-time high TTM EBITDA is -$24.22 M